Predicting micropapillary or solid pattern of lung adenocarcinoma with CT-based radiomics, conventional radiographic and clinical features

被引:0
|
作者
Zhe Wang
Ning Zhang
Junhong Liu
Junfeng Liu
机构
[1] Hebei Medical University Fourth Hospital,Department of Radiology
[2] Hebei Medical University Fourth Hospital,undefined
来源
关键词
Lung adenocarcinoma; Radiomics; Prediction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Dual-energy CT-based radiomics for predicting invasiveness of lung adenocarcinoma appearing as ground-glass nodules
    Zheng, Yuting
    Han, Xiaoyu
    Jia, Xi
    Ding, Chengyu
    Zhang, Kailu
    Li, Hanting
    Cao, Xuexiang
    Zhang, Xiaohui
    Zhang, Xin
    Shi, Heshui
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [32] Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma
    Nie, Pei
    Yang, Guangjie
    Wang, Ning
    Yan, Lei
    Miao, Wenjie
    Duan, Yanli
    Wang, Yanli
    Gong, Aidi
    Zhao, Yujun
    Wu, Jie
    Zhang, Chuantao
    Wang, Maolong
    Cui, Jingjing
    Yu, Mingming
    Li, Dacheng
    Sun, Yanqin
    Wang, Yangyang
    Wang, Zhenguang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (01) : 217 - 230
  • [33] Clinical Impact of Solid or Micropapillary Subtypes in Lung Adenocarcinoma
    Yanagawa, Naoki
    Shiono, Satoshi
    Abiko, Masami
    Katahira, Masato
    Osakabe, Mitsumasa
    Ogata, Shin-Ya
    Sato, Toru
    Tamura, Gen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S777 - S777
  • [34] CT radiomics model combined with clinical and radiographic features for discriminating peripheral small cell lung cancer from peripheral lung adenocarcinoma
    Wang, Jingting
    Zhong, Feiyang
    Xiao, Feng
    Dong, Xinyang
    Long, Yun
    Gan, Tian
    Li, Ting
    Liao, Meiyan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] CT-based conventional radiomics and quantification of intratumoral heterogeneity for predicting benign and malignant renal lesions
    Yu, Shuanbao
    Yang, Yang
    Wang, Zeyuan
    Zheng, Haoke
    Cui, Jinshan
    Zhan, Yonghao
    Liu, Junxiao
    Li, Peng
    Fan, Yafeng
    Jia, Wendong
    Wang, Meng
    Chen, Bo
    Tao, Jin
    Li, Yuhong
    Zhang, Xuepei
    CANCER IMAGING, 2024, 24 (01)
  • [36] Correction to: Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma
    Pei Nie
    Guangjie Yang
    Ning Wang
    Lei Yan
    Wenjie Miao
    Yanli Duan
    Yanli Wang
    Aidi Gong
    Yujun Zhao
    Jie Wu
    Chuantao Zhang
    Maolong Wang
    Jingjing Cui
    Mingming Yu
    Dacheng Li
    Yanqin Sun
    Yangyang Wang
    Zhenguang Wang
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 325 - 327
  • [37] CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinoma
    Yang, Minglei
    She, Yunlang
    Deng, Jiajun
    Wang, Tingting
    Ren, Yijiu
    Su, Hang
    Wu, Junqi
    Sun, Xiwen
    Jiang, Gening
    Fei, Ke
    Zhang, Lei
    Xie, Dong
    Chen, Chang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 876 - +
  • [38] CT-based Radiomics Features Predict Brain Metastasis in Small Cell Lung Cancer
    Wen, Q.
    Jian, Z.
    Linlin, W.
    Xue, M.
    Yong, Y.
    Xindong, S.
    Jinming, Y.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1158 - S1159
  • [39] CT-Based Radiomics Features Predict Brain Metastasis in Small Cell Lung Cancer
    Wen, Q.
    Zhu, J.
    Qiu, Q.
    Bai, T.
    Meng, X.
    Yin, Y.
    Yu, J.
    MEDICAL PHYSICS, 2018, 45 (06) : E171 - E171
  • [40] CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes
    Perez-Johnston, Rocio
    Araujo-Filho, Jose A.
    Connolly, James G.
    Caso, Raul
    Whiting, Karissa
    Tan, Kay See
    Zhou, Jian
    Gibbs, Peter
    Rekhtman, Natasha
    Ginsberg, Michelle S.
    Jones, David R.
    RADIOLOGY, 2022, 303 (03) : 664 - 672